Meyka Pro banner
Adicet Bio, Inc.

Adicet Bio, Inc. (NASDAQ: ACET) Stock Forecast 2027, 2031 & 7-Year Price Prediction

Get the latest Adicet Bio, Inc. (NASDAQ: ACET) stock forecast across short-term and long-term horizons for its NASDAQ listing. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

ACETNASDAQ
HealthcareBiotechnology
$9.23
$0.05(0.54%)
U.S. Market is Open · 15:35

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$9.60
Change↑ $0.37 (4.01%)

Quarterly Forecast

Predicted Price$10.73
Change↑ $1.50 (16.25%)

Yearly Forecast

Predicted Price$9.59
Change↑ $0.36 (3.87%)

3 Years Forecast

Predicted Price$19.23
Change↑ $10.003 (108.37%)

5 Years Forecast

Predicted Price$28.76
Change↑ $19.53 (211.58%)

7 Years Forecast

Predicted Price$41.27
Change↑ $32.04 (347.09%)

Adicet Bio, Inc. Stock Forecast Summary

Adicet Bio, Inc. (ACET) stock is currently priced at $9.23. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $9.60.

In the long term, ACET shows a bullish trend. The 2027 forecast points to $9.59 (3.87% change), while the 2031 forecast suggests $28.76 (211.58% change). Looking 7 years ahead, projections estimate the stock could trade near $41.27, a 347.09% change from today’s price.

Overall Sentiment

Bullish

Short-Term Outlook

Bullish

Long-Term Outlook

Bullish

This mix indicates that Adicet Bio, Inc. stock is expected to trade sideways over the coming years.

Investment Calculator

Estimate your potential returns on ACET using our advanced Investment Calculator with AI-driven price forecasts. Enter your investment amount and select a target date to view expected results, including estimated profit, loss, and ROI performance.

Based on your investment of $1,000.00 in Adicet Bio, Inc. and holding until September 22nd, 2027, you could face a potential +$38.74 profit, reflecting a +3.9% ROI over the next 365 days. These projections help you better understand short-term market movements.

$

$Shares Bought

108.3424

@ $9.23/share

~Forecast Price

$9.59

1-year AI forecast

$Est. Portfolio Value

$1,038.74

+$38.74 profit

%ROI

+3.9%

return on investment

Adicet Bio, Inc. yearly Price Forecast Chart

Explore the yearly forecast chart for ACET, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Adicet Bio, Inc. over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for ACETForecasting details for ACET are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Adicet Bio, Inc. Stock Forecast 2026

The forecast for Adicet Bio, Inc. (ACET) in 2026 suggests a price of $9.59, representing a 3.87% move from today’s price.

Average Target: $9.59

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Adicet Bio, Inc. Stock Forecast 2030

By 2030, Meyka AI projects ACET could trade near $28.76, showing a potential 211.58% compared to current levels.

Average Target: $28.76

Market Outlook: bullish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward Adicet Bio, Inc..

Adicet Bio, Inc. 7-Year Stock Forecast (20322033)

Looking 7 years ahead, the long-term forecast for ACET points to a price around $41.27, which is a projected 347.09% move from today’s level.

Average Target: $41.27

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:
  • Global economic expansion or contraction.
  • Regulatory and policy environment.
  • Adicet Bio, Inc.’s ability to maintain market leadership.

Frequently Asked Questions